Type 1 Diabetes Treatment in RE:YOUTH (YONSEI BH Arterial Stemcell Clinic)

YONSEI BH Arterial Stemcell Clinic offers specialized arterial stem cell therapy for Type 1 Diabetes in Cheonan, South Korea. A single therapy session may cost around $34,600, while a five-session treatment package is typically priced at $153,000, offering savings. The clinic provides the only arterial delivery method in Korea, ensuring 100% stem cell delivery directly to the targeted organ.

About the Treatment Method

The clinic's primary therapy is arterial stem cell therapy. This is a regenerative medicine procedure. It involves the direct arterial delivery of mesenchymal stem cells. The target is the pancreatic and metabolic vasculature. This method differs greatly from traditional intravenous (IV) injections. IV methods may only deliver 5-10% of cells to the target site. Arterial delivery achieves near-total cell delivery to the pancreas. The goal is to address the underlying inflammation. It aims to improve metabolic balance. Most patients require a minimum of five sessions for optimal effect. This therapy is not a cure for Type 1 Diabetes. Full insulin independence is unlikely. Individual results can vary.

Treatment Process and Package

The therapy is administered as part of a structured package. Each session includes a mesenchymal stem cell injection. The package typically includes:

• Personalized program preparation.
• A thorough doctor review and consultation.
• VIP-level patient attention, with a maximum of two patients treated per day.

The comprehensive five-session package offers significant savings compared to single sessions. Patients should note some items are not covered:

• Accommodation, hotel stays, and airport transfers.
• Airline tickets and personal expenses.
• A 10% VAT fee is charged separately from the quoted prices.

Doctor's Expertise

Dr. Byung-hee Lee leads the treatment team. He is an MD with 41 years of extensive experience. His specialization spans radiation oncology, hematology, and vascular surgery. He has performed over 900 procedures in his career. Dr. Lee is the founder of the Korean Society of Interventional Neurology. He is also a published author with 24 SCI publications.

Clinic Accreditation and Approach

RE:YOUTH (YONSEI BH) is accredited by the Korean Institute for Healthcare Accreditation. Its international medical team provides dedicated support. The clinic’s unique focus is on direct organ-targeted stem cell delivery. This approach aims to potentially improve blood glucose variability. It also seeks to reduce pancreatic inflammation and slow autoimmune progression. For those seeking advanced regenerative options for Type 1 Diabetes, this clinic provides a specialized, accredited pathway.